Arcus Biosciences (RCUS) announced the first OS results from Arm A1 of the Phase 2 EDGE-Gastric study in patients with locally advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback